QSP Summit 

Tuesday, April 6 - Thursday, April 8
Virtual | 11am-1pm ET each day

About the Event

qsp

The Quantitative Systems Pharmacology (QSP) Summit is an annual meeting dedicated to fostering an active community of industry and academic participants interested in topics relevant to QSP. In its fourth year, the QSP Summit features talks from key industry and academic researchers and a poster session with awards. No fee is required.  

Poster Awards

Congratulations to the poster award winners!

1st Place: Maral Budak, Postdoctoral Research Fellow at University of Michigan Medical School
"Optimization of multidrug therapies for tuberculosis using a multi-scale computational model"

2nd Place: Vahideh Vakil, PhD Candidate at Rutgers University
"Dose optimization for drug-resistant cancer treatment"

3rd Place: Jonathan Anzules, PhD Candidate at UC Merced
"Modeling Homeostatic Expansion in a Healthy Autoimmune System"

qsp summit

Agenda

11:00AM - Opening Remarks

11:05AM - "Inventing new therapies:  where do they come from and how should they be evaluated?"

                   Michael Rosenblatt, MD

                   Chief Medical Officer, Flagship Pioneering

11:35AM - "Predicting patient-specific therapeutic responses from features of redox metabolism."

                   Melissa Kemp, PhD

                   Professor, Georgia Institute of Technology 

12:05PM - Lightning Talks

12:25PM - "Early Feasibility Analysis of Biotherapeutics."

                  John Burke, PhD, Co-Founder, President & CEO, Applied BioMath

12:55PM - Closing Remarks

11:00AM - Opening Remarks

11:05AM - "Strong intracellular signal inactivation produces sharper and more robust signaling from cell membrane to nucleus."

                   Samuel Isaacson, PhD

                   Associate Professor, Boston University

11:35AM - "A Two-Pore PBPK Model To Predict Systemic PK and Tissue Disposition of Different-Size Proteins."

                   Zhe Li, PhD

                   Senior Clinical Pharmacokineticist, AbbVie

12:05PM - "Quantitative modeling predicts competitive advantages of a next generation anti-NKG2A therapy over monalizumab for the treatment of cancer."

                  Kas Subramanian, PhD, Senior Director, Preclinical Modeling, Applied BioMath

12:35PM - Lightning Talks

12:55PM - Closing Remarks

11:00AM - Opening Remarks

11:05AM - Leslie Sharp, PhD, Chief Scientific Officer, OncoMyx Therapeutics

11:35AM - "Towards a Translational Cerebral Physiologically-Based Pharmacokinetic (PBPK) Model for Monoclonal Antibodies."

                   Hsueh Yuan Chang, PhD

                   Senior Scientist, Boehringer Ingelheim

12:05PM - "Pharmacometrics and Systems Pharmacology Approaches for Development of Cell Therapies."

                    Aman Singh, PhD

                    Associate Director, Clinical Pharmacology M&S, Cell Therapies, Takeda

12:35PM - Lightning Talks

12:55PM - Closing Remarks

Speakers

  • John Burke, PhD, Co-Founder, President & CEO, Applied BioMath
  • Hsueh Yuan Chang, PhD, Senior Scientist, Boehringer Ingelheim
  • Samuel Isaacson, PhD, Associate Professor, Boston University
  • Melissa Kemp, PhD, Professor, Georgia Institute of Technology
  • Zhe Li, PhD, Senior Clinical Pharmacokineticist, AbbVie
  • Michael Rosenblatt, MD, Chief Medical Officer, Flagship Pioneering
  • Leslie Sharp, PhD, Chief Scientific Officer, OncoMyx Therapeutics
  • Aman Singh, PhD, Associate Director of Clinical Pharmacology M&S, Cell Therapies, Takeda
  • Kas Subramanian, PhD, Senior Director, Preclinical Modeling, Applied BioMath